PHARMACOGENOMIC SIGNATURES THAT PREDICT DRUG RESPONSE AND RESISTANCE IN HIGH-GRADE SEROUS OVARIAN CANCER USING PATIENT-DERIVED ORGANOIDS AND THEIR EXOSOMES

University Of Oklahoma, Norman OK

Investigators